abstract |
The present invention relates to methods and pharmaceutical compositions for the treatment of hepatitis B virus-induced infections. In particular, the present invention concerns farnesoid X-receptor agonists (FXR) for use in a method of treating infections caused by the hepatitis B virus in patients in need thereof. |